Chapter 1. Pharmacovigilance Market- Scope & Methodology
1.1    Market Segmentation
1.2    Assumptions
1.3    Research Methodology
1.4    Primary Sources
1.5    Secondary Sources
Chapter 2. Pharmacovigilance Market- Executive Summary
2.1    Market Size & Forecast – (2023 – 2030) ($M/$Bn)
2.2    Key Trends & Insights
2.3    COVID-19 Impact Analysis
          2.3.1    Impact during 2023 – 2030
         2.3.2    Impact on Supply – Demand
Chapter 3. Pharmacovigilance Market- Competition Scenario
3.1    Market Share Analysis
3.2    Product Benchmarking
3.3    Competitive Strategy & Development Scenario
3.4    Competitive Pricing Analysis
3.5    Supplier - Distributor Analysis
Chapter 4. Pharmacovigilance Market- Entry Scenario
4.1     Case Studies – Start-up/Thriving Companies
4.2     Regulatory Scenario - By Region
4.3    Customer Analysis
4.4     Porter's Five Force Model
         4.4.1     Bargaining Power of Suppliers
         4.4.2     Bargaining Powers of Customers
         4.4.3    Threat of New Entrants
         4.4.4    .Rivalry among Existing Players
         4.4.5    Threat of Substitutes
Chapter 5. Pharmacovigilance Market- Landscape
5.1     Value Chain Analysis – Key Stakeholders Impact Analysis
5.2    Market Drivers
5.3    Market Restraints/Challenges
5.4    Market Opportunities 
Chapter 6. Pharmacovigilance Market- By Service Provider 
6.1    In-house
6.2    Contract Outsourcing

Chapter 7. Pharmacovigilance Market- By Product Life Cycle 
7.1    Pre-clinical
7.2    Phase I
7.3    Phase II
7.4    Phase III
7.5    Phase IV
 Chapter 8. Pharmacovigilance Market- By Type 
8.1    Spontaneous Reporting
8.2    Intensified ADR Reporting
8.3    Targeted Spontaneous Reporting
8.4    Cohort Event Monitoring
8.5    EHR Mining
Chapter 9. Pharmacovigilance Market- By Process Flow 
9.1    Case Data Management
         9.1.1    Case Logging
         9.1.2    Case Data Analysis
         9.1.3    Medical Reviewing & Reporting
9.2    Signal Detection
         9.2.1    Adverse Event Logging
         9.2.2    Adverse Event Analysis
         9.2.3    Adverse Event Review & Reporting
9.3    Risk Management System
         9.3.1    Risk Evaluation System
         9.3.2    Risk Mitigation System
Chapter 10. Pharmacovigilance Market- By Therapeutic Area 
10.1    Oncology
10.2    Neurology
10.3    Cardiology
10.4    Respiratory Systems
10.5    Others
Chapter 11. Pharmacovigilance Market- By End Use 
11.1    Pharmaceuticals
11.2    Biotechnology Companies
11.3    Medical Device Manufacturers
11.4    Others
Chapter 12. Pharmacovigilance Market- By Region
12.1    North America
12.2    Europe
12.3    Asia-Pacific
12.4    Latin America
12.5    The Middle East
12.6    Africa
Chapter 13. Pharmacovigilance Market- Company Profiles – (Overview, Product Portfolio, Financials, Developments)
13.1    Company 1
13.2    Company 2
13.3    Company 3
13.4    Company 4
13.5    Company 5
13.6    Company 6
13.7    Company 7
13.8    Company 8
13.9    Company 9
13.10    Company 10
 

Download Sample